SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 15, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 5/10
Horizonweeks Processed6mo ago
Insider cluster: 2 insiders, $11K total
Actionable Insight ▲ Bullish

While the absolute dollar amount is small, the coordinated buying by two C-suite executives at a micro-cap biopharma company may signal positive internal sentiment ahead of potential catalysts. Traders should monitor for upcoming clinical updates or financing news.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
PCSA ▼ -27.03% at T+60d
LONG call ✗ call lost -27.03% · α vs SPY -35.16% · entry $2.96 → $2.16
Entry = T+0 close
Apr 14, 2026
via day close
T+1d
+7.43%
call +7.43% · α +7.18%
$3.18
settled 6mo ago
T+5d
+3.72%
call +3.72% · α +2.08%
$3.07
settled 6mo ago
T+20d
-13.51%
call -13.51% · α -19.56%
$2.56
settled 6mo ago
T+60d
-27.03%
call -27.03% · α -35.16%
$2.16
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two corporate insiders at Processa Pharmaceuticals — the CFO and Chief Development Officer — made open-market purchases totaling approximately $11,235 in the past week, signaling confidence in the company at a time of very low market cap ($8M). The buying is modest in dollar terms but notable given the company's size.

Key Financial Metrics

Direction
buying
Total Value
$11.2K
Insiders
2

Key Facts

  • CFO Russell Skibsted purchased 1,984 shares for $5,892.48 on April 15, 2026.
  • Chief Development Officer Bigora Sian purchased 1,799 shares for $5,343.03 on April 15, 2026.
  • Both purchases were open-market transactions at $2.97 per share.
  • Total cluster value: ~$11,235, representing ~0.14% of the company's $8M market cap.

Financial Impact

$11,235 in insider buying over 7 days, equivalent to 0.14% of market cap

insider sentimentmarket confidence

Risk Factors

  • The total purchase amount is small and may not reflect broad insider conviction.
  • Biopharma stocks at this stage are highly speculative and sensitive to dilution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1776459046655
14 reports for PCSA
Performance horizon
60% Hit rate @ T+5 6 of 10 directional calls Went positive at some point 8 of 10 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
today
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.78 (+1.66%)
Oct 22, 2026
3d ago
DEF 14A
NEUTRAL ★ 4/10
$1.86awaiting T+5—$1.78 (−4.30%)
Oct 9, 2026
16d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.78 (+6.32%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.78 (−12.32%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.78 (−17.59%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.78 (−17.21%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.78 (−17.21%)
Jun 1, 2026
20w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.78 (−39.04%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.78 (−31.80%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.78 (−31.80%)
Showing 10 of 14

US Market Status

Market Open — Closes in 1h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026